Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 4Lymphoid 2Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1CNS 1

Conditions

Myelodysplastic Syndromes 187Leukemia, Myeloid, Acute 159Myeloproliferative Disorders 83Leukemia, Myelogenous, Chronic, BCR-ABL Positive 72Precursor Cell Lymphoblastic Leukemia-Lymphoma 61Primary Myelofibrosis 54Leukemia, Myelomonocytic, Chronic 44Leukemia 35Polycythemia Vera 33Multiple Myeloma 30Hematologic Neoplasms 30Thrombocythemia, Essential 29Lymphoma, Non-Hodgkin 28Leukemia, Biphenotypic, Acute 25Hodgkin Disease 25Lymphoma 23Myelodysplastic-Myeloproliferative Diseases 18Leukemia, Lymphocytic, Chronic, B-Cell 18Leukemia, Myeloid, Chronic-Phase 14Blastic Plasmacytoid Dendritic Cell Neoplasm 14Neoplasms 13Burkitt Lymphoma 12Mastocytosis 11Leukemia, Myeloid 11Graft vs Host Disease 11Blast Crisis 11Anemia, Refractory, with Excess of Blasts 11Lymphoma, Follicular 10Anemia, Aplastic 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8

Interventions

luspatercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × beta-Thalassemia × Myeloid × Clear all
NCT04064060 2026-05-28

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Celgene

Phase 3 Recruiting
665 enrolled
Myeloid

Myelodysplastic Syndromes, Myeloproliferative Disorders, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡